Phibro Animal Health Corp., based in Teaneck, NJ, is one of the world’s leading animal health companies, focused on helping to meet the growing demand for animal protein. They provide livestock producers with a broad range of products and solutions to help maintain and enhance the health and productivity of animals. Stock covered includes beef and dairy cattle, poultry, swine, and even aquaculture. Their products are designed to prevent and treat diseases, as well as improve nutrition.

The company has over 1,100 employees, serving over 2,800 customers globally, and generates net sales in excess of $650 million. They operate in three business segments: Animal Health, Mineral Nutrition, and Performance Products.

• Animal Health – Phibro develops, produces, and markets more than 550 products, including antibacterials, anticoccidials, nutritional specialty products, and vaccines.

• Mineral Nutrition – Phibro makes more than 450 formulations and concentrations of trace minerals, such as zinc, manganese, copper, and iron, to fortify daily feed requirements.

• Performance Products – Phibro makes various specialty ingredients for use in personal care, automotive, industrial chemical, and chemical catalyst industries.

In a press release, the company announced that it has commenced an initial public offering of 11,765,000 shares of its Class A Common Stock, with an estimated price range for the initial public offering of $16 to $18 per share. Phibro has applied to list its Class A Common Stock on The Nasdaq Global Select Market under the symbol “PAHC.”

For additional information, visit www.PAHC.com

Let us hear your thoughts below: